Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) will disclose its interim financial results for the first nine months of 2023 on Sunday, Nov. 7, before the start of the trading session on the Saudi Exchange (Tadawul).
The company will hold an earnings call on the same day at 4:00 p.m. (KSA time) to discuss the operational and financial highlights, as well as the investor's inquiries.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}